Kaishun Xia

Kaishun Xia

Auto-generated profile, based on publicly available information

Kaishun Xia

Department of Orthopedics Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, Zhejiang, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Bioactive Materials
Verified
Journal Article
Open access
CWChenggui Wang
Chenggui Wang
MWMin Wang
Min Wang
KXKaishun Xia
Kaishun Xia
JWJingkai Wang
Jingkai Wang
FCFeng Cheng
Feng Cheng
QCQixin Chen
Qixin Chen
The repair and motor functional recovery after spinal cord injury (SCI) remains a worldwide challenge. The inflammatory microenvironment is one of main obstacles on inhibiting the recovery of SCI. Using mesenchymal stem cells (MSCs) derived extracellular vesicles to replace MSCs transplantation and mimic cell paracrine secretions provides a potential strategy for microenvironment regulation. However, the effective preservation and controlled release of extracellular vesicles in the injured spinal cord tissue are still not satisfied. Herein, we fabricated an injectable adhesive anti-inflammatory F127-polycitrate-polyethyleneimine hydrogel (FE) with sustainable and long term extracellular vesicle release (FE@EVs) for improving motor functional recovery after SCI. The orthotopic injection of FE@EVs hydrogel could encapsulate extracellular vesicles on the injured spinal cord, thereby synergistically induce efficient integrated regulation through suppressing fibrotic scar formation, reducing inflammatory reaction, promoting remyelination and axonal regeneration. This study showed that combining extracellular vesicles into bioactive multifunctional hydrogel should have great potential in achieving satisfactory locomotor recovery of central nervous system diseases.

31 January 2020 in Small
Verified
Journal Article
Closed access
PDF file
JWJingkai Wang
Jingkai Wang
DLDongdong Li
Dongdong Li
CLChengzhen Liang
Chengzhen Liang
CWChenggui Wang
Chenggui Wang
XZXiaopeng Zhou
Xiaopeng Zhou
YSYouqing Shen
Youqing Shen

3 September 2021 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
LYLiwei Ying
Liwei Ying
CWChenggui Wang
Chenggui Wang
KSKesi Shi
Kesi Shi
XZXiaopeng Zhou
Xiaopeng Zhou
ZGZhe Gong
Zhe Gong
QCQixin Chen
Qixin Chen
Transmembrane integrin receptors represent a major component of cell-extracellular matrix (ECM) communications that mediate cellular biological activities, including proliferation and differentiation. Stem cells, especially mesenchymal stem cells (MSC), have rapidly emerged as promising therapies for various diseases. Dynamic links exist between extracellular and intracellular environments that profoundly influence the cellular activities via integrin receptors, such as cell morphology transformation and differentiation. Interpreting the roles of integrin receptors in the regulation of MSC differentiation may potentially lead to an amplified therapeutic effect. In this review, we summarize, for the first time, the potential mechanisms by which integrins promote MSC multilineage differentiation, including integrin downstream signaling cascades and the interactions between integrin and ion channels, the cytoskeleton, and nuclear mechanoresponses. Furthermore, we focus on the current state and future prospects of the application of integrins to promote cell differentiation.